PRODUCT CATEGORIES
HEALTH TOPICS
|
|
ProHealth.com
October 12, 2004
Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):551-4. Epub 2002 Oct 03.
Dolezal T, Krsiak M.
Department of Pharmacology, 3rd Faculty of Medicine, Charles University of Prague, Ruska 87, 100 34 Prague, Czech Republic. Tomas.Dolezal@lf3.cuni.cz
AIM OF INVESTIGATION: Guaifenesin is used as an expectorant and it has been reported to possess muscle relaxant and sedative activity.
Guaifenesin has been used as a component of composite OTC analgesics containing paracetamol for many years. The aim of our study was to ascertain effects of guaifenesin on paracetamol analgesic activity and locomotor performance.
METHODS: Antinociceptive efficacy was tested in mice using an acetic acid (0.7%) writhing test. Locomotor performance was tested in rota-rod test and activity cage. All drugs were given orally and tested in mice.
RESULTS: In combination with a subeffective dose of guaifenesin (200 mg/kg), the ED(50) for paracetamol in the writhing test was significantly lower (82.2 mg/kg) than that of paracetamol administered alone (233.7 mg/kg). Guaifenesin alone did not show an analgesic effect. Guaifenesin did not produce statistically significant locomotor impairment in the rota-rod test at doses enhancing analgesic activity of paracetamol, although there was a trend for decreased locomotor activity in activity cage.
CONCLUSION: The present results indicate that guaifenesin may enhance analgesic activity of paracetamol.
PMID: 12444496 [PubMed - indexed for MEDLINE]
|
|
Stay Up-to-Date with All the Latest News Sign up for our HealthWatch e-Newsletters
|
View Archives »
|
|
|
Get the World's Largest Chronic Fatigue Syndrome & Fibromyalgia Newsletters
View Archives
On Your $49 Order*
The Assault on Chronic Pain in Fibromyalgia and ME/CFS - a Combined Approach [more]
ME/CFS Appears to Be a Disease Affecting the Basal Ganglia & Dopamine Metabolism [more]
Disrupted Sleep and Pain: Breaking the Chain [more]
Oxidative stress linked to headache in fibromyalgia; CoQ10 supports important improvement [more]
Mayo Trial Concludes Amygdala Retraining Can Support Improvements for ME/CFS and Fibromyalgia Patien... [more]
|
|